Form 8-K - Current report:
SEC Accession No. 0001193125-14-253471
Filing Date
2014-06-27
Accepted
2014-06-27 16:59:55
Documents
7
Period of Report
2014-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750687d8k.htm 8-K 17167
2 EX-1.1 d750687dex11.htm EX-1.1 211385
3 EX-4.1 d750687dex41.htm EX-4.1 58540
4 EX-5.1 d750687dex51.htm EX-5.1 5037
5 GRAPHIC g750687ex1_1pg035.jpg GRAPHIC 9302
6 GRAPHIC g750687ex1_1pg036.jpg GRAPHIC 6604
7 GRAPHIC g750687ex1_1pg039.jpg GRAPHIC 25351
  Complete submission text file 0001193125-14-253471.txt   350775
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33221 | Film No.: 14946563
SIC: 2834 Pharmaceutical Preparations